IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

KCK Ltd.

Q4 2022 Holdings

Filed 2023-01-31 | 3 holdings | $66.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Sight Sciences Inc(SGHT)COM82657M105$58.3M4,776,23287.4%
Neuropace Inc(NPCE)COM641288105$8.4M5,621,11112.5%
Aileron Therapeutics Inc(RNTX)COM NEW00887A204$52.9K22,3410.1%